Oxidative one-carbon cleavage of the octyl side chain of olanexidine, a novel antimicrobial agent, in dog liver microsomes

Reference

• AKHTAR, M., NJAR, V. C. 0. and WRIGHT, J. N., 1993, Mechanistic studies on aromatase and related C-C bond cleaving P-450 enzymes. Journal of Steroid Biochemistry and Molecular Biology, 44, 375–387.
   Google Scholar
• BACK, D. J., TJIA, J. F., KARBWANG, J. and COLBERT, J., 1988, In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines. British Journal of Clinical Pharmacology, 26, 23–29.
   PubMed Web of Science ®Google Scholar
• BUENING, M. K. and FRANKLIN, M. R., 1974, The formation of complexes absorbing at 455 nm from cytochrome P-450 and metabolites of compounds related to SKF 525-A. Drug Metabolism and Disposition, 2, 386–390.
   PubMed Web of Science ®Google Scholar
• BYON, C. Y. and GUT, M., 1980, Steric considerations regarding the biodegradation of cholesterol to pregnenolone: exclusion of (22S)-22-hydroxycholesterol and 22-ketocholesterol as intermediates. Biochemical and Biophysical Research Communications, 94, 549–552.
   PubMedGoogle Scholar
• CHAURET, N., GAUTHIER, A., MARTIN, J. and NICOLL-GRIFFITH, D. A., 1997, In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse. Drug Metabolism and Disposition, 25, 1130–1136.
   PubMed Web of Science ®Google Scholar
• COOK, C. S., BERRY, L. M., KIM, D. H., BURTON, E. G., HRIBAR, J. D. and ZHANG, L., 2002, Involvement of CYP3A in the metabolism of eplerenone in humans and dogs: differential metabolism by CYP3A4 and CYP3A5. Drug Metabolism and Disposition, 30, 1344–1351.
   PubMed Web of Science ®Google Scholar
• CORINA, D. L., MILLER, S. L., WRIGHT, J. N. and AKHTAR, M., 1991, The mechanism of cytochrome P-450 dependent C-C bond cleavage: studies on 17a-hydroxylase-17,20-lyase. Journal of the Chemical Society Chemical Communications, 782–783.
   Google Scholar
• GUENGERICH, F. P., KIM, D. H. and IwAsAKI, M., 1991, Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chemical Research in Toxicology, 4, 168–179.
   PubMed Web of Science ®Google Scholar
• HARVEY, D. J., 1989, Further studies on the oxidative cleavage of the pentyl side-chain of cannabinoids: identification of new biotransformation pathways in the metabolism of 3'-hydroxy-delta-9-tetrahydrocannabinol by the mouse. Xenobiotica, 19, 1437–1447.
   PubMed Web of Science ®Google Scholar
• HARVEY, D. J., 1990, Oxidative cleavage of the pentyl side-chain of cannabinoids. Drug Metabolism and Disposition, 18, 350–355.
   PubMedGoogle Scholar
• HARVEY, D. J. and LEUSCHNER, J. T. A., 1985, Studies on the 13-oxidative metabolism of Al- and Y-tetrahydrocannabinol in the mouse. Drug Metabolism and Disposition, 13, 215–219.
   PubMed Web of Science ®Google Scholar
• JANSEN, G. A., VAN DEN BRINK, D. M., OFMAN, R., DRAGHICI, 0., DACREMONT, G. and WANDERS, R. J., 2001, Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid a-oxidation pathway is localized in peroxisomes. Biochemical and Biophysical Research Communications, 283, 674–679.
   Google Scholar
• KOBAYASHI, S., MURRAY, S., WATSON, D., SESARDIC, D., DAVIES, D. S. and BOOBIS, A. R., 1989, The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man. Biochemical Pharmacology, 38, 2795–2799.
   PubMed Web of Science ®Google Scholar
• KUDO, S., IWASAKI, M., SUGIMOTO, K., KODAMA, R. and ODOMI, M., 1998a, Absorption, distribution and excretion of OPB-2045 following a single subcutaneous administration to rats. Xenobiotic Metabolism and Disposition, 13, 1–7.
   Google Scholar
• KUDO, S., IWASAKI, M., SUGIMOTO, K., KODAMA, R. and ODOMI, M., 1998b, Absorption, distribution and excretion of OPB-2045 following a single subcutaneous administration to beagle dogs. Xenobiotic Metabolism and Disposition, 13, 8–12.
   Google Scholar
• KUDO, S., UMEHARA, K., MORITA, S., UCHIDA, M., MIYAMOTO, G. and ODOMI, M., 1998c, Metabolism of 1-(3,4-dichlorobenzy1)-5-octylbiguanide in the dog. Xenobiotica, 28, 507–514.
   PubMed Web of Science ®Google Scholar
• KUDO, S., UMEHARA, K., ODOMI, M. and MIYAMOTO, G., 1998d, Metabolism of a new bactericidal antiseptic, OPB-2045, in rats following subcutaneous administration. Xenobiotic Metabolism and Disposition, 13, 346–350.
   Google Scholar
• Lu, A. Y. H., SOMOGYI, A., WEST, S., KUNTZMAN, R. and CONNEY, A. H., 1972, Pregnenolone-16a-carbonitrile: A new type of inducer of drug-metabolizing enzymes. Archives of Biochemistry and Biophysics, 125, 457–462.
   Google Scholar
• MANNAERTS, G. P., VAN VELDHOVEN, P. P. and CASTEELS, M., 2000, Peroxisomal lipid-degradation via 13- and a-oxidation in mammals. Cell Biochemistry and Biophysics, 32, 73–87.
   PubMed Web of Science ®Google Scholar
• MILLER, S. L., WRIGHT, J. N., CORINA, D. L. and AKHTAR, M., 1991, Mechanistic studies on pregnene side-chain cleavage enzyme (17a-hydroxylase-17,20-lyase) using 180. Journal of the Chemical Society Chemical Communications, 157–159.
   Google Scholar
• MINATO, K., Koizumi, N., HONMA, S., IWAMURA, S. and TsuKAmoTo, K., 1999, Characterizations of mouse hepatic microsomal monooxygenase catalyzing 11P-hydroxylation of osaterone acetate. Biochemical Pharmacology, 58, 335–341.
   PubMedGoogle Scholar
• OHGURO, K., OHNISHI, H., TOMIGASHI, N., TSUBOUCHI, H. and KIKUCHI, M., 1997, Bactericidal activity of OPB-2045: a new antiseptic. Paper presented at the 20th International Congress of Chemotherapy, 29 June-3 July, Sydney, Australia.
   Google Scholar
• ORTIZ DE MONTELLANO, P. R., 1995, Oxygen activation and reactivity. In P. R. Ortiz de Montellano (ed.), Cytochrome P450: Structure, Mechanism, and Biochemistry, 2nd edn (New York: Plenum), pp. 245–303.
   Google Scholar
• OTTON, S. V., CREWE, H. K., LENNARD, M. S., TUCKER, G. T. and WOODS, H. F., 1988, Use of quinidine inhibition to define the role of the sparteine/debrisoquine cytochrome P450 in metoprolol oxidation by human liver microsomes. Journal of Pharmacology and Experimental Therapeutics, 247, 242–247.
   PubMed Web of Science ®Google Scholar
• ROUSSEL, F., DUIGNAN, D. B., LAWTON, M. P., OBACH, R. S., STRICK, C. A. and TWEEDIE, D. J., 1998, Expression and characterization of canine cytochrome P450 2D15. Archives of Biochemistry and Biophysics, 357, 27–36.
   PubMed Web of Science ®Google Scholar
• SAKAGAMI, Y., KAjimuEA, K. and NISHIMURA, H., 2000, Electron-microscopic study of the bactericidal effect of OPB-2045, a new disinfectant produced from biguanide group compounds, against methicillin-resistant Staphylococcus aureus. Journal of Pharmacy and Pharmacology, 52, 1547–1552.
   PubMedGoogle Scholar
• SAKAGAMI, Y., MIMURA, M., KAJIMURA, K., YOKOYAMA, H. and NISHIMURA, H., 1999, Electron-microscopic study of the bactericidal effect of OPB-2045, a new mono-biguanide disinfectant produced from biguanide group compounds, against Pseudomonas aeruginosa. Journal of Pharmacy and Pharmacology, 51, 201–206.
   PubMed Web of Science ®Google Scholar
• SAMARA, E., BIALER, M., BAR-ON, H. and HARVEY, D. J., 1990, Identification of metabolites of the 1", 1"-dimethylheptyl analogue of cannabidiol in rat and dog in vivo. Xenobiotica, 20, 447–455.
   PubMed Web of Science ®Google Scholar
• SHIKITA, M. and HALL, P. F., 1974, The stoichiometry of the conversion of cholesterol and hydroxycholesterols to pregnenolone (33-hydroxypregn-5-en-20-one) catalysed by adrenal cytochrome P-450. Proceedings of the National Academy of Sciences, USA, 71, 1441–1445.
   PubMedGoogle Scholar
• SMITH, D. A., 1991, Species differences in metabolism and pharmacokinetics: are we close to an understanding? Drug Metabolism Reviews, 23, 355–373.
   PubMed Web of Science ®Google Scholar
• SMITH, D. A. and JoNEs, B. C., 1992, Speculations on the substrate structure—activity relationship (SSAR) of cytochrome P450 enzymes. Biochemical Pharmacology, 44, 2089–2098.
   PubMed Web of Science ®Google Scholar
• SONDERFAN, A. J., ARLOTTO, M. P., DUTTON, D. R., MCMILLEN, S. K. and PARKINSON, A., 1987, Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450. Archives of Biochemistry and Biophysics, 255, 27–41.
   PubMed Web of Science ®Google Scholar
• STROBL, G. and WOLFF, T., 1991, Molecular basis of drug metabolism interactions: a structural model for inhibitors of debrisoquine hydroxylase. Naunyn-Schmiedeberg's Archives of Pharmacology, 343(Suppl.), R8.
   Google Scholar
• TAKAHASHI, T., TAKAHASHI, H., TAKEDA, H. and SHICHIRI, M., 1992, Alpha-oxidation of fatty acids in fasted or diabetic rats. Diabetes Research and Clinical Practice, 16, 103–108.
   PubMedGoogle Scholar
• TASSANEEYAKUL, W., BIRKETT, D. J., VERONESE, M. E., McMANus, M. E., TUKEY, R. H., QUATTROCHI, L. C., GELBOIN, H. V. and MINERS, J. 0., 1993, Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. Journal of Pharmacology and Experimental Therapeutics, 265, 401–407.
   Google Scholar
• TSUBOUCHI, H., OHGURO, K., YASUMURA, K., ISHIKAWA, H. and KIKUCHI, M., 1997, Synthesis and structure—activity relationships of novel antiseptics. Bioorganic and Medicinal Chemistry Letters, 7, 1721–1724.
   Google Scholar
• UMEHARA, K., KUDO, S., HIRAO, Y., MORITA, S., OHTANI, T., UCHIDA, M. and MIYAMOTO, G., 2000b, In vitro characterization of the oxidative cleavage of the octyl side chain of olanexidine, a novel antimicrobial agent, in dog liver microsomes. Drug Metabolism and Disposition, 28, 1417–1424.
   PubMed Web of Science ®Google Scholar
• UMEHARA, K., KUDO, S., HIRAO, Y., MORITA, S., UCHIDA, M., ODOMI, M. and MIYAMOTO, G., 2000a, Oxidative cleavage of the octyl side chain of 1-(3,4-dichlorobenzy1)-5-octylbiguanide (OPB-2045) in rat and dog liver preparations. Drug Metabolism and Disposition, 28, 887–894.
   PubMed Web of Science ®Google Scholar
• VAMECQ, J. and DRAYE, J.-P., 1988, The enzymatic and mass spectrometric identification of 2-oxophytanic acid, a product of the peroxisomal oxidation of L-2-hydroxyphytanic acid. Biomedical and Environmental Mass Spectrometry, 15, 345–351.
   Google Scholar
• VERHOEVEN, N. M., JAKOBS, C., CARNEY, G., SOMERS, M. P., WANDERS, R. J. and Rizzo, W. B., 1998, Involvement of microsomal fatty aldehyde dehydrogenase in the a-oxidation of phytanic acid. FEBS Letters, 429, 225–228.
   PubMed Web of Science ®Google Scholar
• WANDERS, R. J. A. and VAN ROERMUND, C. W. T., 1993, Studies on phytanic acid a-oxidation in rat liver and cultured human skin fibroblasts. Biochemica et Biophysica Acta, 1167, 345–350.
   Google Scholar
• WATKINS, P. B., WRIGHTON, S. A., MAUREL, P., SCHUETZ, E. G., MENDEZ-PICON, G., PARKER, G. A. and GUZELIAN, P. S., 1985, Identification of an inducible form of cytochrome P-450 in human liver. Proceedings of the National Academy of Sciences, USA, 82, 6310–6314.
   Google Scholar
• WRIGHTON, S. A., STEVENS, J. C., BECKER, G. W. and VANDENBRANDEN, M., 1993, Isolation and characterization of human liver cytochrome P450 2C19: correlation between 2C19 and S-mephenytoin 4'-hydroxylation. Archives of Biochemistry and Biophysics, 306, 240–245.
   PubMed Web of Science ®Google Scholar